Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950363 · ClinicalTrials.gov registry record
Physician Mental Health Study for Medical Trainees
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 40
- Enrollment target
NCT02950363: Completed study, sponsored by Scripps Translational Science Institute.
NCT02950363 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02950363 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether use of a suite of smart phone enabled mobile health devices can reduce burnout in medical trainees. Such applications can then be used in more general populations with the same goal in mind.
Primary Outcome
Maslach Burnout Inventory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-07 |
What the finished NCT02950363 record still lists
NCT02950363 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02950363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02950363 about?
NCT02950363 is a clinical study titled "Physician Mental Health Study for Medical Trainees". The purpose of this study is to determine whether use of a suite of smart phone enabled mobile health devices can reduce burnout in medical trainees. Such applications can then be used in more general populations with the same goal in mind.
What is the current status of trial NCT02950363?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-07. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT02950363?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia